The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report
Fuqiang Cui(Peking University), Daniel Low‐Beer(World Health Organization), Shevanthi Nayagam(Imperial College London), Mónica Alonso González(Consumer Healthcare Products Association), Casimir Manzengo Mingiedi(World Health Organization Regional Office for Africa), Timothy B. Hallett(Imperial College London), Devin Razavi-Shearer, Catherine de Martel(Centre international de recherche sur le cancer), Ahmed Sabry Alaama(World Health Organization Regional Office for the Eastern Mediterranean), Diana Faini(Ifakara Health Institute), Mae Dirac(Institute for Health Metrics and Evaluation), L Olufunmilayo(World Health Organization), Mohamed Amine Ghrabi, Homie Razavi, Polin Chan(World Health Organization Regional Office for South-East Asia), Meg Doherty(World Health Organization), Niklas Luhmann(World Health Organization), Peter Vickerman(University of Bristol), Antons Mozalevskis(World Health Organization), Kiyohiko Izumi(World Health Organization Regional Office for the Western Pacific)
Cited by 6
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Global, regional and national burden of primary liver cancer by subtype
|European Journal of Cancer|2021|581
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Requirements for global elimination of hepatitis B: a modelling study
|The Lancet Infectious Diseases|2016|384